{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:24:19Z","timestamp":1760189059761},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"S1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":9374,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The International Journal of Cell Cloning"],"published-print":{"date-parts":[[1990]]},"DOI":"10.1002\/stem.5530080728","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T11:20:50Z","timestamp":1246533650000},"page":"293-302","source":"Crossref","is-referenced-by-count":21,"special_numbering":"supplement S1","title":["Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor"],"prefix":"10.1093","volume":"8","author":[{"given":"Peter","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Negrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Donlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1002\/stem.5530080728-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V67.6.1765.1765","article-title":"Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes","volume":"67","author":"Jacobs","year":"1986","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood.V61.6.1035.1035","article-title":"The smoldering myeloid leukemic states: clinical and biologic features","volume":"61","author":"Greenberg","year":"1983","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB3|cit3","first-page":"973","article-title":"In vitro culture techniques defining biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disorders","volume":"15","author":"Greenberg","year":"1986","journal-title":"Clin Haematol"},{"key":"10.1002\/stem.5530080728-BIB4|cit4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JCO.1986.4.3.325","article-title":"Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes No 5 and 7","volume":"4","author":"LeBeau","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1002\/stem.5530080728-BIB5|cit5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.V73.1.248.248","article-title":"Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin","volume":"73","author":"Janssen","year":"1989","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB6|cit6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1002\/stem.5530080728-BIB7|cit7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1985.tb07329.x","article-title":"Myelodysplastic syndromes: a scoring system with prognostic significance","volume":"59","author":"Mufti","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1002\/stem.5530080728-BIB8|cit8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/1097-0142(19850801)56:3<553::AID-CNCR2820560323>3.0.CO;2-Q","article-title":"Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases","volume":"56","author":"Foucar","year":"1985","journal-title":"Cancer"},{"key":"10.1002\/stem.5530080728-BIB9|cit9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.1987.tb06138.x","article-title":"Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases","volume":"65","author":"Kerhofs","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1002\/stem.5530080728-BIB10|cit10","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1073\/pnas.79.14.4347","article-title":"Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein","volume":"79","author":"Lotem","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/stem.5530080728-BIB11|cit11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.1978.tb05826.x","article-title":"Annotation: the differentiation of myeloid leukemia cells-new possibilities for therapy","volume":"40","author":"Sachs","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1002\/stem.5530080728-BIB12|cit12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910280318","article-title":"In vitro inhibition of the development of myeloid leukemia by injection of macrophage and granulocyte-inducing protein","volume":"28","author":"Lotem","year":"1981","journal-title":"Int J Cancer"},{"key":"10.1002\/stem.5530080728-BIB13|cit13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ijc.2910300213","article-title":"Regulator-induced suppression of myelomonocytic leukemic cells: clonal analysis of early cellular events","volume":"30","author":"Metcalf","year":"1982","journal-title":"Int J Cancer"},{"key":"10.1002\/stem.5530080728-BIB14|cit14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V71.3.703.703","article-title":"Randomized study of 13 cis-retinoic acid vs. placebo in the myelodysplastic disorders","volume":"71","author":"Koeffler","year":"1988","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1200\/JCO.1986.4.12.1857","article-title":"A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes","volume":"4","author":"Chesson","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1002\/stem.5530080728-BIB16|cit16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V67.2.257.257","article-title":"The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors","volume":"67","author":"Metcalf","year":"1986","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB17|cit17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V70.3.657.657","article-title":"The effects of three recombinant growth factors, IL-3, GM-CSF and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short term suspension culture","volume":"70","author":"Miyauchi","year":"1987","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1182\/blood.V69.6.1771.1771","article-title":"The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia","volume":"69","author":"Vellenga","year":"1987","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB19|cit19","article-title":"In vitro effects of recombinant human granulocyte and granulocyte-monocyte colony stimulating factors on hemopoiesis in the myelodysplastic syndromes","volume":"70","author":"Nagler","year":"1987","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB20|cit20","unstructured":"Nagler A Ginzton N Bangs C Donlon T Greenberg PL Leukemia 1989"},{"key":"10.1002\/stem.5530080728-BIB21|cit21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood.V65.1.190.190","article-title":"Immunologic selection of hemopoietic precursor cells utilizing antibody-mediated plate binding (\u201cpanning\u201d)","volume":"65","author":"Greenberg","year":"1985","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB22|cit22","article-title":"In vitro hemopoiesis in myelodysplastic syndrome patients treated with recombinant human granulocyte colony stimulating factor","volume":"72","author":"Nagler","year":"1988","journal-title":"Blood"},{"key":"10.1002\/stem.5530080728-BIB23|cit23","unstructured":"Nagler A Mackichan ML Ginzton N In vitro responsiveness of marrow hemopoietic precursors in myelodysplastic syndromes following treatment with recombinant human G-CSF"},{"key":"10.1002\/stem.5530080728-BIB24|cit24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.7326\/0003-4819-110-12-976","article-title":"Treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor","volume":"110","author":"Negrin","year":"1989","journal-title":"Ann Int Med"},{"key":"10.1002\/stem.5530080728-BIB25|cit25","doi-asserted-by":"crossref","unstructured":"Negrin RS Haeuber DH Nagler A Olds T Vincent M Greenberg P Persistent improvement in neutrophil counts and decreased incidence of infection in patients with myelodysplastic syndromes chronically treated with recombinant human granulocyte colony stimulating factor (G-CSF) 1989","DOI":"10.1182\/blood.V76.1.36.36"},{"key":"10.1002\/stem.5530080728-BIB26|cit26","unstructured":"Negrin RS Haeuber DH Nagler A Donlon T Souza L Greenberg P Effects of maintenance treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor, (submitted)"},{"key":"10.1002\/stem.5530080728-BIB27|cit27","doi-asserted-by":"crossref","unstructured":"Nagler A Negrin RS Ginzton N Donlon T Souza LM Greenberg PL In vitro hemopoiesis in myelodysplastic syndrome patients on maintenance therapy with recombinant human granulocyte colony stimulating factor 1989","DOI":"10.1182\/blood.V76.1.36.36"}],"container-title":["The International Journal of Cell Cloning"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.5530080728","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/stem.5530080728\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T21:34:05Z","timestamp":1685050445000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/8\/S1\/293-302\/6386597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"references-count":27,"journal-issue":{"issue":"S1"},"URL":"https:\/\/doi.org\/10.1002\/stem.5530080728","relation":{},"ISSN":["0737-1454","1549-4918"],"issn-type":[{"value":"0737-1454","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990]]}}}